Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 174 (RNA5SP174)

Target
RNA5SP174
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA
01

Overview

RNA, 5S ribosomal pseudogene 174 (RNA5SP174) is a non-coding pseudogene annotated in the human genome, derived from the 5S ribosomal RNA gene family[2][5]. Unlike the functional 5S rRNA genes, which are essential components of the ribosome and involved in protein synthesis[1][3][9], RNA5SP174 does not encode a functional RNA molecule or protein. Instead, it is classified as a processed pseudogene, likely originating from the reverse transcription and genomic insertion of a processed 5S rRNA transcript, but it no longer produces a product or participates in any biological pathway[4][5]. There are hundreds of non-functional 5S rRNA pseudogenes in the genome, reflecting the historical accumulation of these sequences over evolution[4][9]. RNA5SP174 is not considered a “target” in the therapeutic or pharmacological sense, and its presence has no known implications for drug development, disease, or clinical practice[2][5].

Other names
RN5S174RNA5SP174RNA, 5S ribosomal 174
02

Mechanism of action

no mechanism; not a target for drug action

03

Biological functions

does not have a known biological function; not transcribed into functional RNA or protein
04

Disease associations

no evidence of direct disease association; not implicated in cancer, inflammatory, or other human diseases
05

Safety considerations

no therapeutic or safety relevance
06

Interacting drugs

pseudogenes do not serve as pharmacological targets
07

Biomarkers

not used as a biomarker

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 174 (RNA5SP174).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 174 (RNA5SP174).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call